Literature DB >> 8405402

Cloning, characterization and overexpression of a Streptococcus pyogenes gene encoding a new type of mitogenic factor.

M Iwasaki1, H Igarashi, Y Hinuma, T Yutsudo.   

Abstract

A new type of mitogenic factor, termed MF, has been found in the culture supernatant of Streptococcus pyogenes and its N-terminal amino acid sequence has been determined. On the basis of this sequence, an S. pyogenes gene encoding MF was cloned and its nucleotide sequence was determined. The MF gene includes a long, open reading frame with 813 nucleotides capable of encoding the MF precursor protein with 271 amino acids. Removal of the putative 43 residues as a signal peptide results in the mature MF protein with 228 amino acids. The molecular mass of the mature MF is calculated as 25,363 which is consistent with the previously determined value of 25,370 for MF secreted from S. pyogenes. Neither nucleotide nor amino acid sequence homology was found between the mature MF and other streptococcal pyrogenic exotoxins, such as SPE A, SPE B and SPE C. The mature MF was recombinantly overexpressed as a fusion protein with glutathione S-transferase in Escherichia coli. The recombinant protein showed mitogenic activity in rabbit peripheral blood lymphocytes and immunoreactivity with the rabbit antiserum raised against the secreted MF from S. pyogenes. These data indicate that a unique gene encoding MF was cloned from S. pyogenes.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8405402     DOI: 10.1016/0014-5793(93)80323-m

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  19 in total

1.  Pyrogenicity and cytokine-inducing properties of Streptococcus pyogenes superantigens: comparative study of streptococcal mitogenic exotoxin Z and pyrogenic exotoxin A.

Authors:  H Müller-Alouf; T Proft; T M Zollner; D Gerlach; E Champagne; P Desreumaux; C Fitting; C Geoffroy-Fauvet; J E Alouf; J M Cavaillon
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

2.  Streptococcal pyrogenic exotoxin F (SpeF) causes permeabilization of lung blood vessels.

Authors:  M Matsumoto; N Ishikawa; M Saito; K Shibayama; T Horii; K Sato; M Ohta
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

3.  Streptococcal DNase B is immunologically identical to superantigen SpeF but involves separate domains.

Authors:  A Eriksson; B Eriksson; S E Holm; M Norgren
Journal:  Clin Diagn Lab Immunol       Date:  1999-01

Review 4.  Group A streptococcus--from basic science to clinical disease.

Authors:  D L Stevens
Journal:  West J Med       Date:  1996-01

5.  Physical and genetic chromosomal map of an M type 1 strain of Streptococcus pyogenes.

Authors:  A N Suvorov; J J Ferretti
Journal:  J Bacteriol       Date:  1996-09       Impact factor: 3.490

6.  Streptococcal mitogenic exotoxin Z, a novel acidic superantigenic toxin produced by a T1 strain of Streptococcus pyogenes.

Authors:  Y Kamezawa; T Nakahara; S Nakano; Y Abe; J Nozaki-Renard; T Isono
Journal:  Infect Immun       Date:  1997-09       Impact factor: 3.441

7.  Localization of biologically important regions on toxic shock syndrome toxin 1.

Authors:  D L Murray; C A Earhart; D T Mitchell; D H Ohlendorf; R P Novick; P M Schlievert
Journal:  Infect Immun       Date:  1996-01       Impact factor: 3.441

8.  Characterization of the canine type C enterotoxin produced by Staphylococcus intermedius pyoderma isolates.

Authors:  V M Edwards; J R Deringer; S D Callantine; C F Deobald; P H Berger; V Kapur; C V Stauffacher; G A Bohach
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

9.  Mitogenicity of M5 protein extracted from Streptococcus pyogenes cells is due to streptococcal pyrogenic exotoxin C and mitogenic factor MF.

Authors:  K H Schmidt; D Gerlach; L Wollweber; W Reichardt; K Mann; J H Ozegowski; B Fleischer
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

10.  Superantigenic properties of the group A streptococcal exotoxin SpeF (MF).

Authors:  A Norrby-Teglund; D Newton; M Kotb; S E Holm; M Norgren
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.